MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 16th August, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company, comprising information related to issue of duplicate share certificates of the company. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letters dated 13th August, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company regarding loss of share certificates of the company. Morepen Laboratories Ltd - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 12th August, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company regarding loss of share certificate of the company. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 09th August, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company, comprising information related to issue of duplicate share certificate of the company. Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find attached transcript of 'Analyst/ Investor Conference Call' organised on Tuesday, 27th July 2021 at 04.00 P.M. (IST) subsequent to declaration of unaudited standalone and consolidated financial results for the quarter ended 30th June 2021. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 30th July, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company regarding loss of share certificate of the company. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 27th July, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company, comprising information related to issue of duplicate share certificates of the company.
Earnings Call for Q1FY22 of Morepen Laboratories
Conference Call with Morepen Laboratories Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript. Morepen Laboratories Ltd - 500288 - Statement Of Deviation Or Variation In Utilization Of Funds Raised Pursuant To Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there is no deviation or variation in utilization of funds raised, in the quarter ended June 30, 2021. Please find enclosed nil statement of deviation or variation in this regard.
Morepen Labs Profit Rises 57% In June Quarter, Stock Gains 3%
Morepen Laboratories reported a net profit of Rs 30.47 crore on a consolidated basis in the April-June quarter of the financial year 2021-22